Peptide · Research Monograph · Growth hormone-releasing hormone (GHRH) analog; N-terminal 29-amino-acid fragment of human GHRH

Sermorelin

Prompts your body to make its own growth hormone naturally

Sermorelin is a growth-hormone-releasing peptide researched for prompting the body to make its own growth hormone naturally - supporting recovery, sleep, and healthy aging while keeping the body's normal hormonal rhythm intact.

For laboratory research use only - not for human or animal use

In the Exactamino catalog - Sermorelin from $100

Molecular data

Molecular formulaC149H246N44O42S
Molecular weight3357.93 Da
SequenceTyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg
Sequence length29 residues
CAS / identifier86168-78-7
Physical formLyophilized powder
Available sizes10mg

How it works

GHRH-R

GHRH Receptor Agonism

Sermorelin binds growth hormone-releasing hormone receptors on anterior-pituitary somatotrophs, stimulating the synthesis and pulsatile release of endogenous growth hormone rather than supplying it exogenously.

  • Activates pituitary somatotrophs
  • Pulsatile GH release
  • Endogenous secretion
GH → IGF-1

Downstream IGF-1 Signaling

Increased growth hormone drives hepatic production of insulin-like growth factor 1 (IGF-1), the principal mediator of GH's anabolic and metabolic effects on muscle, bone, connective tissue, and lipid metabolism.

  • Hepatic IGF-1 synthesis
  • Protein anabolism
  • Lipolytic signaling
Feedback

Preserved Physiologic Rhythm

Because stimulation acts upstream at the pituitary, GH output remains subject to somatostatin and IGF-1 negative feedback, helping maintain a natural secretory rhythm instead of a fixed exogenous level.

  • Somatostatin-regulated
  • Negative feedback intact
  • Natural pulsatility
Upstream

Stimulates, Not Replaces

Unlike recombinant HGH, which delivers growth hormone directly, Sermorelin prompts the pituitary to release its own GH - preserving the hypothalamic-pituitary axis and its regulatory checkpoints.

  • Works upstream of GH
  • HP axis preserved
  • Self-limiting response
Half-Life

Short Plasma Half-Life

Sermorelin has a brief plasma half-life on the order of minutes, producing transient GH pulses that more closely resemble natural secretory bursts than the sustained elevation seen with exogenous GH.

  • ~10-20 min half-life
  • Transient GH pulses
  • Mimics physiology
Sequence

GHRH(1-29) Active Fragment

Sermorelin corresponds to the first 29 amino acids of human GHRH - the shortest fully active N-terminal sequence - making it a well-characterized research probe of the somatotropic axis.

  • 29-residue peptide
  • Fully active fragment
  • Well-characterized

What the research shows

Endocrine

Growth Hormone Axis

Used as a research probe of pituitary GH secretory reserve; the GHRH stimulation test has historically been employed to assess somatotroph function.

GHRH stimulation literature

Body Composition

Lean Mass & Adiposity

GH secretagogues are studied for their influence on lean body mass, fat mass, and metabolic rate in models of age- or disease-related GH decline.

Body-composition research

Sleep & Recovery

Slow-Wave Sleep

Endogenous GH release is tightly coupled to slow-wave sleep, so GHRH analogs are studied to explore the link between the somatotropic axis and sleep architecture.

Sleep-axis research

Aging Research

Somatopause

Age-related decline in GH and IGF-1 - termed somatopause - is modeled with GHRH analogs to investigate restoration of more youthful secretory patterns.

Aging-axis research

Specification

Compound ClassGrowth hormone-releasing hormone (GHRH) analog
Research NameSermorelin (GHRH 1-29)
SequenceN-terminal 29-amino-acid fragment of human GHRH
TargetGHRH receptor (pituitary somatotrophs)
FormLyophilized powder
Molecular Weight3,357.93 g/mol
Purity≥99% (HPLC verified)
TestingThird-party HPLC, Mass Spec, Endotoxin
Half-Life~10-20 minutes (plasma)
Storage (lyophilized)-20°C for long-term stability
Storage (reconstituted)2-8°C, use within 14 days
SolubilityBacteriostatic water for reconstitution
COAIncluded with every order
Molecular FormulaAvailable on request
AppearanceWhite to off-white powder
Quantity5mg
Stability24 months from manufacture date when stored properly

Frequently asked questions

What is Sermorelin?

Sermorelin is a synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH) - the shortest fully active fragment. It stimulates the pituitary to secrete the body's own growth hormone in a natural, pulsatile fashion.

How is Sermorelin different from HGH?

Recombinant HGH supplies growth hormone directly, whereas Sermorelin stimulates endogenous GH release by acting upstream at the pituitary. This preserves the hypothalamic-pituitary feedback loop and a more physiologic secretory rhythm.

What is the molecular weight and purity?

Sermorelin has a molecular weight of 3,357.93 g/mol. Every vial is supplied at ≥99% purity, verified by HPLC, with a Certificate of Analysis included.

How should it be stored?

Keep lyophilized vials at -20°C for long-term stability. After reconstitution with bacteriostatic water, refrigerate at 2-8°C and use within approximately 14 days.

Is this product for human use?

No. Sermorelin is sold strictly as a research compound for laboratory and in-vitro use only. It is not intended for human or animal consumption, diagnosis, or treatment.

Literature

  • Clin Interv Aging Sermorelin: A Better Approach to Management of Adult-Onset Growth Hormone Insufficiency? 2006 · Walker RF
  • BioDrugs Sermorelin: A Review of Its Use in the Diagnosis and Treatment of Idiopathic Growth Hormone Deficiency 1999 · Prakash A, Goa KL
  • Endocr Rev Human Growth Hormone and Human Aging 1993 · Corpas E, Harman SM, Blackman MR

For laboratory research use only. Not a drug, supplement, or medical product; not for human or animal use. All findings referenced are from published preclinical/laboratory research.